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Abstract
The CFTR (cystic fibrosis transmembrane conductance regulator) protein is a large polytopic protein whose biogenesis is
inefficient. To better understand the regulation of CFTR processing and trafficking, we conducted a genetic screen that
identified COMMD1 as a new CFTR partner. COMMD1 is a protein associated with multiple cellular pathways, including the
regulation of hepatic copper excretion, sodium uptake through interaction with ENaC (epithelial sodium channel) and NF-
kappaB signaling. In this study, we show that COMMD1 interacts with CFTR in cells expressing both proteins endogenously.
This interaction promotes CFTR cell surface expression as assessed by biotinylation experiments in heterologously
expressing cells through regulation of CFTR ubiquitination. In summary, our data demonstrate that CFTR is protected from
ubiquitination by COMMD1, which sustains CFTR expression at the plasma membrane. Thus, increasing COMMD1
expression may provide an approach to simultaneously inhibit ENaC absorption and enhance CFTR trafficking, two major
issues in cystic fibrosis.
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Introduction
The cystic fibrosis transmembrane conductance regulator
(CFTR) is a cAMP-regulated Cl
- channel encoded by the gene
mutated in cystic fibrosis (CF) [1]. CF is the most common severe
autosomal recessive genetic disorder in Caucasians. The lack of
CFTR function at the apical membrane of epithelial cells is the
cause of the morbidity and mortality associated with the disease
[2]. CFTR is a 1480 amino acid glycoprotein predicted to consist
of two membrane-spanning domains, each containing six
transmembrane domains (TMD), two cytoplasmic nucleotide-
binding domains, a regulatory region and four intracytoplasmic
loops (ICLs) connecting the TMDs on the cytoplasmic side of the
protein [1]. CFTR is a large polytopic protein whose biogenesis is
inefficient and slow, with 60–80% of CFTR being degraded in the
endoplasmic reticulum (ER) [3,4]. It is the first integral membrane
protein shown to be a substrate for ER-associated degradation
(ERAD) via the ubiquitin proteasome system. Proteasomal
degradation occurs in both the wild-type CFTR (wt-CFTR) and
the disease-associated F508del mutant [5,6]. Ubiquitination can
also regulate CFTR at the plasma membrane and internalized
CFTR can either be ubiquitinated and diverted for lysosomal
degradation or can be recycled back to the cell surface [7–10].
However, identifying new regulators of CFTR membrane
trafficking in post-Golgi compartments is still a major research
issue.
COMMD1, previously known as MURR1 (Mouse U2af1-rs1
region 1), is the prototype of a new family of 10 proteins
containing COMM (Copper Metabolism gene MURR1) domains, from
COMMD1 to COMMD10 [11]. COMMD1 is ubiquitously
expressed and was first identified as being involved in the
regulation of hepatic copper excretion [12]. A growing body of
data suggests that COMMD1 is associated with the ubiquitin
proteasome system and regulates the stability of proteins such as
NF-kB subunits, ATP7B and HIF-1a [13,14].
To better understand the regulation of CFTR processing and
trafficking, we performed a yeast two-hybrid screen using the
third intracytoplasmic loop (ICL3) of CFTR as bait [15]. Two
ICL3 mutations (S945L, D979A) are associated with the CF
phenotype (Figure 1A), suggesting the importance of this region
in the maturation and/or function of CFTR [16,17]. COMMD1
was found to exhibit specific and strong binding to ICL3. Our
data provide evidence that COMMD1 interacts with CFTR and
promotes CFTR cell surface expression through inhibition of
CFTR ubiquitination. Regulation of the ubiquitin pathway is
one of the basic functions of the COMMD1 protein, which has
been shown to contribute to protein degradation [13]. More
recently, COMMD1 was also reported to regulate channel cell
surface expression, and has been shown to modulate sodium
transport in epithelial cells through regulation of ENaC cell
surface expression [18]. We suggest that COMMD1 may
function as part of the endocytic machinery, helping to regulate
the intracellular trafficking process. In addition, COMMD1 may
act as a scaffold for protein ubiquitination, thereby affecting
protein trafficking.
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COMMD1 and CFTR interact in epithelial cells
A yeast two-hybrid screen was performed to identify proteins
that interact with CFTR amino acids Leu937 to Pro988
(Figure 1A) [15]. One of 36 clones contained a cDNA insert with
a near full-length human COMMD1 coding sequence (amino
acids 5–190). To assess whether the association of CFTR and
COMMD1 had any biological and physiological relevance, we
first conducted co-immunoprecipitation experiments with both
full-length proteins. We used the human HT-29 colon adenocar-
cinoma cell line because it expresses both CFTR and COMMD1
endogenously and was previously used for co-immunoprecipitation
experiments [15]. CFTR is a 170 kDa glycoprotein whose
processing can be assessed by examining its glycosylation status
[19]. Electrophoresis of immunoprecipitated wt-CFTR resulted in
two close bands (Figure 1B). The first of these was a diffuse band of
approximately 170 kDa (band C), representing the mature, fully
glycosylated protein processed through the Golgi complex. The
second was a thin band of approximately 140 kDa (band B),
representing the core-glycosylated protein located in the endo-
plasmic reticulum. Co-immunoprecipitation experiments per-
formed on HT-29 cells showed an association between COMMD1
and wt-CFTR in vivo when using anti-CFTR antibody (Figure 1B).
Switching the antibodies used for immunoprecipitation and
immunoblotting showed that COMMD1 interacted not only with
the core-glycosylated form of CFTR but also with the fully
glycosylated form of CFTR, since both bands could be detected
clearly on the gel.
COMMD1 is a member of a family defined by the presence of a
conserved and unique motif named the COMM domain, which
functions as an interface for protein-protein interactions [11].
Therefore, we analyzed the role of this domain in the CFTR-
COMMD1 interaction by constructing N-terminal-tagged
COMMD1 mammalian vectors (Figure 1C). A full-length
construct (Myc-COMMD1) and a COMM domain-truncated
construct (Myc-COMMD1DCOMM) were transiently transfected
in HeLa cells stably expressing wt-CFTR [15]. Co-immunopre-
cipitation experiments clearly showed that the COMM domain
was required for the CFTR-COMMD1 interaction (Figure 1D)
and confirmed that both glycosylated forms of CFTR were able to
bind to COMMD1.
COMMD1 regulates CFTR cell surface expression
Studies on the Wilson disease protein showed that COMMD1
participates in the ATP7B-mediated copper-excretion pathway
[20]. The exact function of COMMD1 in this pathway remains
elusive, but it has been shown to regulate ATP7B trafficking [21].
Furthermore, COMMD1 was recently shown to be involved in
ENaC cell surface expression [18]. To determine if COMMD1
participates in CFTR trafficking, we first examined the role of its
overexpression on the maturation of the CFTR glycoprotein.
Then, we examined CFTR cell surface expression through
biotinylation experiments. We observed that a 2-fold overexpres-
sion of COMMD1 did not change the amounts of the individual B
and C bands, nor did it alter the C/B+C ratio, which indicates
that it did not affect CFTR maturation (Figure 2A). However, as
shown in Figure 2C, overexpression of COMMD1 increased the
cell surface expression of CFTR protein by 20% (11968%).
CFTR expression was normalized to Na/K-ATPase expression.
These results were confirmed by immunostaining showing that
cells transfected with COMMD1 exhibited an intense plasma
membrane staining compared to cells in the same field expressing
COMMD1 endogenously (Figure 2D). Taken together, these
results indicate that COMMD1 overexpression enhances CFTR
cell surface expression.
Loss-of-function studies were conducted using RNA-mediated
interference, in which endogenous COMMD1 expression was
reduced to 35% of control (Figure 2B). The steady-state level of
CFTR was not affected; however, biotinylation experiments
clearly showed a 30% decrease in CFTR membrane expression
(7269%) (Figure 2C). Immunostaining confirmed that CFTR
expression was strongly reduced at the cell surface even if
COMMD1 was not completely silenced (Figure 2D). Therefore,
we can conclude that COMMD1 down-regulation inhibits CFTR
cell surface expression.
COMMD1 subcellular distribution
Endogenous COMMD1 subcellular distribution is both nuclear
and cytoplasmic, with cytoplasmic expression restricted to
vesicular compartments, as observed in HeLa cells [12]. To
further define the intracellular localization of COMMD1, double-
labeling experiments of COMMD1 and organelle markers were
performed in our wt-CFTR expression model (Figure 3). Distri-
bution of COMMD1 did not overlap with the ER marker
calnexin, the trans-Golgi network marker 58k or the endosomal
marker Rab4. Partial colocalization was observed with the
recycling endosome markers Rab11 and EHD1. The best
colocalization was observed with the transferrin receptor (TfR),
which is a marker of early/recycling endosomes.
COMMD1 regulates CFTR ubiquitination
Several studies indicate that COMMD1 is a regulator of protein
ubiquitination involved in ENaC trafficking and in the HIF-1 and
NF-kB pathways [22–25]. Within the NF-kB pathway,
COMMD1 promotes the ubiquitination of RelA, whereas it
Figure 1. COMMD1 and CFTR interact in mammalian cells. (A) Sequences of ICL3 in other species from fish to primates. Asterisks indicate the
position of two class II mutations: S945L and D979A. Identity of amino acids between the different proteins are boxed in black, conserved residues are
boxed in dark gray and semi-conserved substitutions in light gray. (B) Representative gels for the same co-immunoprecipitation experiments in HT-29
cells expressing endogenous CFTR and COMMD1. Lysates from HT-29 cells were immunoprecipitated (IP) with either 0.8 mg of anti-COMMD1 mAb
(Abnova), 0.8 mg of anti-CFTR mAb (MAB25031, R&D Systems) or with 0.8 mg anti-mouse IgG as a control. Each immunoprecipitation sample was then
split in half and loaded onto an 8% SDS-PAGE for CFTR detection and 11% SDS-PAGE for COMMD1 detection. Both gels were transferred to PVDF
membrane and subjected to immunoblotting (IB). The 8% SDS-PAGE membrane was probed with anti-CFTR mAb (MM13-4) and the 11% SDS-PAGE
membrane with a rabbit anti-COMMD1 pAb (Proteintech Group). Both membranes were probed with anti-a-tubulin as control (11% gel is shown).
Filled and empty arrowheads indicate the fully- (170 kDa) and core-glycosylated (140 kDa) CFTR, respectively. * indicates mouse IgG light chain from
the antibody used for immunoprecipitation. (C) COMMD1 constructions in pcDNA3.1/Topo plasmid. Two COMMD1 constructs were generated by
adding a Myc-tag at the N-terminus of COMMD1: Myc-COMMD1 and a construct with a deletion of the COMM domain named Myc-COMMD1DCOMM.
(D) Representative gels for the same co-immunoprecipitation experiment between COMMD1 and wt- in heterologous system. HeLa cells stably
expressing wt- (spTCF-wt) or empty CFTR vector (spTracer) as control were transfected with Myc-COMMD1. spTCF-wt were transfected with Myc-
COMMD1DCOMM. Lysates from all these experiments were subjected to SDS-PAGE, as in (B) after CFTR IP. The 8% SDS-PAGE membrane was probed
with anti-CFTR mAb and the 11% SDS-PAGE membrane with anti-c-Myc mAb. Both membranes were probed with anti-a-tubulin as control (11% gel
is shown).
doi:10.1371/journal.pone.0018334.g001
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test whether COMMD1 expression affects CFTR ubiquitination
in HeLa cells stably expressing wt-CFTR. Immunoprecipitation
followed by immunoblotting showed that the overall expression of
CFTR did not change when COMMD1 was up- or down-
regulated (Figure 4A), which is consistent with results from whole
cell lysates (Figure 2A and 2B). The amount of ubiquitinated
CFTR was then assessed in the absence of proteasome inhibitors
by blotting the same membrane with a monoclonal anti-ubiquitin
antibody (Figure 4A, right panel). Densitometric analysis showed
that the relative amount of ubiquitinated CFTR normalized to
total CFTR was significantly altered with respect to COMMD1
expression (Figure 4B). COMMD1 down-regulation increased
ubiquitinated CFTR (126615%), whereas its overexpression
decreased ubiquitinated CFTR (7768%). No change was
observed in total protein ubiquitination. HeLa cells stably
expressing wt-CFTR were transiently transfected with Myc-
COMMD1, vector alone or COMMD1 siRNA and subsequently
Figure 2. COMMD1 regulates CFTR cell surface expression. (A) HeLa cells stably expressing wt-CFTR were transiently transfected with an
empty COMMD1 vector (mock, pcDNA3.1/Topo) or Myc-COMMD1, and were biotinylated with Sulfo-NHS-LC-biotin. Lysates from all these
experiments were subjected to SDS-PAGE directly (input) or pulled-down with streptavidin-agarose (biotin). Representative gels for the same samples
were separated by 8% SDS-PAGE for CFTR, Na/K-ATPase detection and 11% SDS-PAGE for COMMD1, a-tubulin detection. (B) HeLa cells stably
expressing wt-CFTR were transiently transfected with a siCONTROL Non-Targeting siRNA (mock) or COMMD1 siRNA and further processed as in (A).
Filled and empty arrowheads indicate the fully- (170 kDa) and core-glycosylated (140 kDa) CFTR, respectively. (C) Quantification of CFTR cell surface
expression. The biotinylated CFTR level is normalized to the biotinylated Na/K-ATPase level. Endogenous COMMD1 expression is referred as 100%,
with mock being pcDNA3.1/Topo for overexpression experiments (A), whereas mock was siCONTROL for silencing experiments (B). The means 6 S.D.
were obtained from three independent experiments.* P,0.05 was determined by t-test. (D) Immunofluorescence microscopy of COMMD1 and CFTR
in HeLa cells stably expressing wt-CFTR. Cells were transfected with Myc-COMMD1 or COMMD1 siRNA for overexpression and silencing studies,
respectively, and not transfected for endogenous expression studies. Two types of light exposure microscopy (short and normal) are shown to
visualize all expression conditions. Scale bars: 10 mm.
doi:10.1371/journal.pone.0018334.g002
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different time intervals. Immunoblotting of whole cell lysates
demonstrated that when COMMD1 was overexpressed, mature
CFTR stability was notably increased compared to controls
(Figure 4C and 4D). Altogether, these data clearly demonstrate
that COMMD1 affects CFTR protein stability and selectively
regulates CFTR ubiquitination without affecting the overall
ubiquitination process.
COMMD1 regulates CFTR ubiquitination through an ICL3
motif
As part of the yeast two-hybrid screen, targeted two-hybrid tests
between COMMD1 and ICL3 mutants S945L and D979A were
conducted. A loss of interaction was observed with S945L,
suggesting that the substitution of Ser-945 disrupts the ICL3/
COMMD1 interaction in yeast in contrast to that of Asp-979 (data
not shown). Since our results showed that COMMD1 overex-
pression inhibited CFTR ubiquitination selectively, we hypothe-
sized that well-conserved lysine residues located in the ICL3
domain could be potential ubiquitin targets. Three lysines were
mutated to arginine in the ICL3 domain near Ser-945 (K946R
and K951R) and Asp-979 (K978R). Mutant CFTR proteins were
transiently transfected in HeLa cells. When COMMD1 was
overexpressed, ubiquitination of K946R- and K951R-CFTR was
increased (15263% and 126615%, respectively) whereas ubiqui-
tination of wt-CFTR was decreased (70615%) (Figure 5A and
5B). The difference between mock-transfected and COMMD1-
transfected cells was not significant in the case of mutant K978R-
CFTR. Thus, COMMD1 overexpression led to a decrease in
ubiquitinated wt-CFTR in both stably- and transiently-transfected
cells. However, ubiquitination of K946R-CFTR and K951R-
CFTR was significantly increased compared to that of wt-CFTR
(Figure 5B). The co-immunoprecipitation experiments between
COMMD1 and each of the three mutant CFTR proteins did not
show any loss of interaction between COMMD1 and CFTR
(Figure 5C). Altogether, these data clearly demonstrate that the
ICL3 CFTR residues located from Ser-945 to Lys-951 are
implicated in the interaction with COMMD1 (Figure 5D).
Discussion
COMMD1 is a recently identified protein that is associated with
multiple cellular pathways. Initially described as a protein involved
in copper metabolism [26], a growing number of studies have
identified COMMD1-associated proteins in sodium transport
[27], NF-kB signaling [11,23], HIF-1 signaling [25], ubiquitina-
tion [23,24] and apoptosis [28]. Thus, COMMD1 is now
considered to be a pleiotropic protein with various cellular
functions [14].
Figure 3. COMMD1 colocalization with organelle markers. (A)
Cartoon indicating the location of the different markers (red), CFTR
(violet) processing throughout the cell and the intracellular localization
of COMMD1 (green). (B) Double-labeling studies with organelle markers
were performed in stably expressing wt-CFTR HeLa cells. Immunostain-
ing was performed on fixed and permeabilized cells using rabbit
primary antibody (anti-COMMD1 pAb 1:100) followed by Alexa Fluor
488-conjugated goat anti-rabbit secondary antibody (green), and each
organelle marker was labeled with mouse primary antibodies (calnexin
1:400, 58k Golgi 1:100, Rab4 1:100, Rab11 1:100, EHD1 1:100, TfR 1:200)
followed by Alexa Fluor 555-conjugated goat anti-mouse secondary
antibody (red). Non-immune anti-mouse and anti-rabbit controls were
conducted to remove non-specific signals. Fluorescence images of cells
were captured and analyzed with a Zeiss Axio Observer Z.1 confocal
microscope with x63 objective. Scale bars: 10 mm.
doi:10.1371/journal.pone.0018334.g003
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that this interaction occurs with both the immature and mature
forms of the CFTR protein in cells expressing endogenous CFTR
and COMMD1. Overexpression of COMMD1 led to a 20%
increase in CFTR on the cell surface, whereas its down-regulation
decreased CFTR cell surface expression by 35%. These results
imply that CFTR cell surface expression is partly regulated by the
COMMD1/CFTR interaction. We also show that COMMD1 is
predominantly localized in the early/recycling endosomes and is
absent from the ER and the trans-Golgi network. COMMD1 is
located in the vesicles of the endocytic pathway as was previously
observed in untransfected HeLa cells [12] and in HepG2 cells
[29]. Our data expand on these studies and show that COMMD1
is located in early/recycling endosomes in the cytoplasm, whereas
little protein is detected in the TGN. EHD1, also known as Rme-
1, was initially described as a regulator of the TfR recycling from
the endocytic recycling compartment to the plasma membrane
[30]. Since then, EHD1 has been reported to regulate the
recycling of a wide array of receptors, including CFTR [31]. We
observed a partial colocalization between COMMD1 and these
three proteins (CFTR, TfR, EHD1), suggesting that COMMD1 is
involved in recycling. Indeed, COMMD1/CFTR colocalization
was observed in a peripheral vesicular compartment. In addition,
COMMD1 loss-of-function studies, in which CFTR cell surface
expression was strongly reduced, showed a functional interaction
between both proteins in such compartments. The presence of
COMMD1 may influence the fate of CFTR by shifting the
equilibrium from recycling and apical membrane expression to
endocytosis. Internalized membrane proteins can be either
targeted for degradation or recycled back to the plasma
membrane, as demonstrated in a recent study where COMMD1
down-regulated ENaC trafficking [18].
Recently, COMMD1 was shown to bind with high specificity to
an important signaling and regulatory lipid, phosphatidylinositol
4,5-bisphosphate (PIP2), and to be localized to the endosomal
compartment, where it forms oligomers stabilized by interactions
with lipids [29]. PIP2 anchors numerous signaling and cytoskeletal
molecules to the cell membrane and plays various roles in
membrane trafficking. Ion transporters and channels are regulated
by PIP2. Phospholipid microdomains are thought to assemble PIP2
binding partners into signaling complexes and to control the
activity of ion transporters and channels, such as ENaC [32] and
Figure 4. COMMD1 regulates CFTR ubiquitination. (A) Representative gels for the same CFTR IP experiment with MAB25031 from HeLa cells
stably expressing wt-CFTR and separated on 8% SDS-PAGE transferred to PVDF membrane. Half of the membrane was probed with anti-CFTR mAb
and the other half with anti-ubiquitin mAb. Lysates were loaded onto an 11% SDS-PAGE and sequential probing of the membrane was performed
(COMMD1, a-tubulin and lastly ubiquitin). Filled and empty arrowheads indicate the fully- (170 kDa) and core-glycosylated (140 kDa) CFTR,
respectively. (B) Quantification of ubiquitinated CFTR. Ratio of ubiquitinated CFTR to total CFTR in each condition is shown, endogenous COMMD1
expression is referred as 100%. The means 6 S.D. were obtained from five independent experiments.* P,0.05 was determined by t-test. (C) Stability
of the mature wt-CFTR was determined upon inhibition of protein biosynthesis with cycloheximide (CHX). Cells were incubated in the presence of
cycloheximide for the indicated time intervals. (D) Quantification of mature CFTR was normalized to a-tubulin level.
doi:10.1371/journal.pone.0018334.g004
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that COMMD1 and CFTR could be recruited transiently in such
domains, as could ENaC.
The pleiotropic functions of COMMD1 have been attributed to
its role in the regulation of protein degradation [14]. This
conclusion was based on results describing COMMD1 function
withinthecopper homeostasis, HIF-1andNF-kB pathways [11,23–
25]. Within the NF-kB pathway, COMMD1 specifically promotes
the ubiquitination and subsequent nuclear proteasomal degradation
of RelA, whereas it protects IkBa from the same outcome in the
cytoplasm. Recently, COMMD1 was described as being associated
with ENaC trafficking through ubiquitination of the channel at the
cell surface and inhibition of channel recycling [18]. In this study,
we show that down-regulation of COMMD1 increases ubiquiti-
nated CFTR, whereas its overexpression decreases ubiquitinated
CFTR. These experiments were performed without proteasome
inhibitors to observe exclusively the effect of COMMD1 without
alteringoverallproteinstabilityanddegradation. Enhanced stability
due to impaired proteasomal degradation was described for IkBa,
indicating that COMMD1 might have the same effect as a
proteasome inhibitor, enhancing and sustaining phospho-IkB
expression [23]. Our results reveal a similar mechanism by which
COMMD1 selectively regulates CFTR trafficking through ubiqui-
tination and leads to increased CFTR stability.
Critical residues within ICL3 have been identified, namely Ser-945
and Lys-946, through mutagenesis experiments that showed a loss of
Figure 5. COMMD1 regulates CFTR ubiquitination through an ICL3 motif. (A) HeLa cells were transfected with CFTR constructs (wt, K946R,
K951R or K978R-CFTR) and Myc-COMMD1 or empty vector as control (mock). The same quantities of lysates were immunoprecipitated with anti-CFTR
mAb (MAB25031). Representative gels for the same experiment where each immunoprecipitation sample was then split in half and loaded onto two
8% SDS-PAGEs for CFTR detection and ubiquitin detection. Both gels were transferred to PVDF membrane and subjected to immunoblotting (IB).
Lysates were loaded onto an 11% SDS-PAGE and sequential probing of the membrane was performed (COMMD1, a-tubulin and lastly ubiquitin).
Filled and empty arrowheads indicate the fully- (170 kDa) and core-glycosylated (140 kDa) CFTR, respectively. (B) Quantification of ubiquitinated
CFTR. Ratio of ubiquitinated CFTR to total CFTR in cells transfected with Myc-COMMD1 compared to the same ratio in mock-transfected cells was
reported as 100% for each independent experiment. The means 6 S.D. were obtained from five to three independent experiments.* P,0.05 is
determined by t-test. (C) Representative gels for the same co-immunoprecipitation experiment between COMMD1 and wt, K946R, K951R or K978R-
CFTR in heterologous system. HeLa cells were co-transfected with Myc-COMMD1 or empty vector (mock) and wt, K946R, K951R or K978R-CFTR.
Lysates from all these experiments were subjected to SDS-PAGE after CFTR IP. The 8% SDS-PAGE membrane was probed with anti-CFTR mAb and the
11% SDS-PAGE membrane with anti-c-Myc mAb. Both membranes were probed with anti-a-tubulin as control (11% gel is shown). (D) Proposed
model of COMMD1 interaction through its COMM domain with the N-terminal end of ICL3 to modulate CFTR ubiquitination.
doi:10.1371/journal.pone.0018334.g005
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COMMD1 overexpression clearly inhibited wt-CFTR ubiquitina-
tion, whereas it strongly induced ubiquitination of K946R- and
K951R-CFTR. These results demonstrate that COMMD1 interacts
through its COMM domain with the N-terminal end of ICL3 to
modulate CFTR ubiquitination (Figure 4D).Thus, ICL3 is critical for
COMMD1-mediated CFTR ubiquitination.
Ubiquitination is the major mode of regulation for the
subcellular localization and turnover of member proteins.
Ubiquitination of integral membrane proteins mediates their
post-endocytic sorting to lysosomes, and a role for ubiquitination
in the internalization of such proteins from the plasma membrane
is emerging [34]. Recently, Ubiquitin Specific Protease-10
(USP10) has been shown to deubiquitinate CFTR in early
endosomes and to enhance the endocytic recycling of CFTR
[9]. We propose that COMMD1 might act as a scaffold in the
endocytic compartment, recruiting enzymes required for the
regulation of the ubiquitination of several membrane transporters.
COMMD1 interacts with an E3 ubiquitin-ligase, X-linked
inhibitor apoptosis (XIAP) [28], and a number of subunits of E3
ubiquitin-ligase complexes such as SCF
bTrCP [23] and ECS
SOCS1
[11,24,35]. USP10 and a still unidentified E3 ligase could
cooperate in such a scaffold to regulate the sorting of CFTR
protein to the cell surface [9]. However, the temporal recruitment
of these factors remains to be determined.
Regulation of the ubiquitin pathway was proposed to be the
basis of many of the functions of the COMMD protein family
contributing to protein degradation [13]. We suggest that
COMMD1 might have a specific function within the endocytic
machinery, where COMMD1-mediated ubiquitination might
alter protein trafficking either by enhancing the cell surface
expression of CFTR or by enhancing the internalization of ENaC.
A main feature of CF is the abnormal balance between fluid and
electrolyte transport, leading to reduced chloride secretion with
abnormal sodium absorption in the pulmonary epithelium [2]. A
number of cellular functions have been attributed to CFTR,
among which is the down-regulation of the transepithelial sodium
transport mediated by ENaC [36]. Increasing COMMD1
expression may provide an approach to simultaneously inhibit
ENaC absorption and enhance CFTR trafficking, two major issues
underlying CF pathogenesis.
Materials and Methods
Antibodies
The following antibodies wereused: MAB25031 (clone 24-1, R&D
systems) and MM13-4 (Upstate), anti-CFTR monoclonal antibodies
(mAb), anti-c-MYC mAb (9E10, BD Biosciences), anti-COMMD1
mouse mAb (2A12, Abnova) and rabbit pAb (Proteintech Group),
mouse anti-Ub (P4D1, Santa Cruz Biotechnology), mouse anti-a-
tubulin (12G10) and anti-a-subunit Na/K-ATPase a5( D S H B ,
University of Iowa), goat anti-EHD1 (A20, Santa Cruz Biotechnol-
ogy), mouse anti-TfR (clone H68.4, Zymed Laboratories), mouse
anti-58k Golgi protein and mouse anti-calnexin (ab6284 and
ab31290, Abcam), anti-Rab4 and -Rab11 mouse antibodies (BD
Biosciences), Alexa Fluor 488 and 555-conjugated goat anti-mouse or
anti-rabbit (Molecular Probes), horse radish peroxidase (HRP)-
conjugated secondary antibodies (Pierce Biotechnology Inc) and
HRP-conjugated secondary anti-IgG1 antibody (SouthernBiotech).
Plasmids constructs and siRNA
The entire coding sequences of the human COMMD1 cDNA
was isolated by PCR from a human brain cDNA library and
subcloned into the plasmid pcDNA3.1/V5-His Topo (Invitrogen).
Myc-COMMD1 and Myc-COMMD1DCOMM mutants were
constructed using the Gene-Editor kit (Promega) and the resulting
mutants were fully sequenced. CFTR plasmids were constructed in
the expression vector pTracer-CMV (Invitrogen) as previously
described [15]. COMMD1 siRNA sequence was 59-GUCUAUUGC-
GUCUGCAGAC-39 [23]. ON-TARGETplus SMARTpool of 4
siRNA was used. Control siRNA was siCONTROL Non-Targeting to
demonstrate the absence of off-targets effects (Dharmacon Inc).
Cell culture and transfection
HT-29 (ATCC, HTB-38), HeLa (ATCC, CCL-2) and HeLa
cells stably transfected with wild-type CFTR (spTCF-wt) or
pTracer (spTracer) were cultured and transfected as described
[15].
Immunofluorescent staining
Immunofluorescent staining was performed as previously
described [15]. Cells were incubated overnight at 4uC with
primary antibody (MAB25031 1:200, rabbit pAb anti-COMMD1
1:100, calnexin 1:400, 58k Golgi 1:100, Rab4 1:100, Rab11 1:100,
EHD1 1:100, TfR 1:200). Control non-immune anti-mouse and
anti-rabbit were used to remove non-specific signals. Fluorescence
images of cells were captured and analyzed with a Leica DMR
epifluorescence and a Zeiss Axio Observer Z.1 confocal
microscope.
Co-immunoprecipitation (CoIP)
Transfected cells were harvested in PBS1X, pelleted at 1000 g
at 4uC and resuspended in 300 ml Co-IP buffer as previously
described [15]. After preclearing, 70 mg of lysate was withdrawn
for measurement of protein loading and the remaining material
was incubated with 0.8 mg anti-CFTR (R&D Systems) or 0.8 mg
anti-COMMD1 (Abnova) overnight at 4uC.
Biotinylation and pull-down assays
Cells were washed three times in ice-cold PBS1X and then
exposed to 0.25 mg/ml Sulfo-NHS-LC-biotin (Pierce Biotech-
nology Inc) in PBS1X for 30 minutes at 4uC. Cells were rinsed
three times with PBS1X and then with glycine quenching buffer
(Tris 50 mM, NaCl 125 mM, Glycine 190 mM, pH 7.4). Cells
were harvested in glycine quenching buffer, pelleted at 1000 g at
4uC and lysed in 300 ml RIPA buffer. After preclearing, equal
amounts of protein, as measured by the Bradford assay (Pierce
Biotechnology Inc.), were used for enrichment of cell surface
proteins by biotinylation and for loading controls (70 mgo f
lysate). The samples were incubated with streptavidin beads pre-
equilibrated with RIPA buffer for 30 minutes at 4uC. The beads
were washed four times with RIPA buffer. The biotinylation
samples were subjected to SDS-PAGE and then analyzed by
western blotting.
Immunoprecipitation for ubiquitination assays
CFTR protein immunoprecipitation using MAB25031 was
performed as previously described [15]. The totality of the
immunoprecipitated sample was loaded into two halves on two
lanes and subjected to SDS-PAGE 8% followed by western
blotting analysis.
CHX chase
In some experiments designed to monitor the kinetics of the
mature CFTR protein, cells were incubated in the presence of
100 mg/ml cycloheximide (CHX) and input (70 mg of lysate) was
subjected to SDS-PAGE 8% followed by western blotting analysis.
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Western blot analysis and quantification was conducted on a
Syngene BioImaging GeneGnome by lowest slope baseline
correction. Data are presented as mean 6 SE. Statistical
significance was assessed by Student’s t-test. Statistical significance
was set at P,0.05; n indicates the number of independent
experiments.
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